DUBLIN, Aug. 7, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/qhvzwh/world) has announced the addition of the "World Anti-Inflammatory Therapeutics - Market Opportunities and Forecasts, 2014 - 2020" report to their offering.
Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks to eliminate the cause of injury, clear dead and necrotic cells and heal injured tissues. Sometimes, the body defense system inappropriately triggers inflammation against its own cells, resulting in incurable inflammatory autoimmune diseases such as arthritis, asthma and chronic obstructive pulmonary disease (COPD). According to World Health Organization (WHO), approximately 235 million people suffer from asthma in the world.
The global anti-inflammatory therapeutics market is expected to grow at a CAGR of 5.9% over the forecast period, owing to the emergence of anti-inflammatory biologics that are more targeted, effective and with lesser side effects as compared to conventional drugs. In addition, they are also difficult to imitate due to their complex molecular structure and origin.
KEY MARKET BENEFITS:
- The report provides a quantitative analysis of the current market and estimations during 2014 - 2020 that assist in identifying the prevailing market opportunities to capitalize.
- Exhaustive analysis of the global anti-inflammatory therapeutics market by product type helps in understanding the types of therapeutics that are currently being used along with the categories that would gain prominence in the future.
- Competitive intelligence (of leading manufacturers and distributors of anti-inflammatory therapeutics) helps in understanding the competitive scenario across the geographies.
- Comprehensive analysis of factors that drive and restrict the growth of the global anti-inflammatory therapeutics market is provided
- - Abbvie
- - Amgen
- - AstraZeneca PLC
- - Eli Lily and Company
- - F. Hoffman
- - GlaxoSmithKline
- - Johnson & Johnson
- - La Roche AG
- - Merck & CO.
- - Novartis
- - Pfizer
Key Topics Covered:
Chapter: 1 REPORT DESCRIPTION
Chapter: 2 EXECUTIVE SUMMARY
Chapter: 3 MARKET OVERVIEW
Chapter: 4 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY INDICATION
Chapter: 5 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY DRUG CLASS
Chapter: 6 GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET BY GEOGRAPHY
Chapter: 7 COMPANY PROFILES
For more information visit http://www.researchandmarkets.com/research/qhvzwh/world
Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets